| Entry |
|
|---|
| Name |
Soybean oil (JP18/USP);
Intrafat (TN);
Intralipid (TN) |
|---|
| Product |
INTRALIPID (Baxter Healthcare Corporation), INTRALIPID (Baxter Healthcare CORP), INTRALIPID (Baxter Healthcare Corporation), INTRALIPID (Baxter Healthcare Corporation), INTRALIPID (Baxter Healthcare Corporation), INTRALIPID (HF Acquisition Co LLC), NUTRILIPID I.V. FAT EMULSION (B. Braun Medical) |
|---|
| Component |
Genistein [CPD:C06563], Daidzin [CPD:C10216], Linoleate [CPD:C01595], Oleic acid [CPD:C00712], Palmitic acid [CPD:C00249], Octadecatrienoic acid [CPD:C06427], Stearic acid [CPD:C01530]
|
|---|
| Source |
Glycine max [TAX:3847]
|
|---|
| Remark |
| Therapeutic category: | 3299 7121 |
| Product (mixture): | D04798<JP> D05287<JP> |
|
|---|
| Efficacy |
Supplement (nutrient), Pharmaceutic aid (ointment base) |
|---|
| Comment |
Glycine max Merrill (Leguminosae) seed fatty oil
|
|---|
| Interaction |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
32 Nutrients, tonics
329 Miscellaneous
3299 Others
D04962 Soybean oil (JP18/USP)
7 Agents not mainly for therapeutic purpose
71 Dispensing medicines
712 Ointment bases
7121 Oil bases
D04962 Soybean oil (JP18/USP)
Crude drugs [BR:br08305]
Dicot plants: rosids
Fabaceae (pea family)
D04962 Soybean oil
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Crude drugs
D04962 Soybean oil
|
|---|
| Other DBs |
|
|---|